Cargando…

Making core outcomes more clinically meaningful: 2-for-the-price-of-1 with a distributional approach

Detalles Bibliográficos
Autores principales:	Peacock, Janet L, Lo, Jessica W, Sauzet, Odile
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460927/ http://dx.doi.org/10.1186/1745-6215-16-S1-P16

Ejemplares similares

Making continuous outcomes meaningful to clinicians
por: Peacock, Janet L, et al.
Publicado: (2011)

Core harm outcome sets developed by drug are needed to allow informed risk-benefit decision making
por: Cornelius, Victoria, et al.
Publicado: (2015)

Usability and consistency of harm information in drug product descriptions: a matched comparison of data between the United States (US) and Europe
por: Cornelius, Victoria R, et al.
Publicado: (2015)

Dichotomisation using a distributional approach when the outcome is skewed
por: Sauzet, Odile, et al.
Publicado: (2015)

Dichotomisation of a continuous outcome and effect on meta-analyses: illustration of the distributional approach using the outcome birthweight
por: Ofuya, Mercy, et al.
Publicado: (2014)

Adverse event reporting in randomised trials of neuropathic pain: challenges for clinical usefulness of safety data
por: Cornelius, Victoria R, et al.
Publicado: (2011)

Core outcomes for randomized trials and core information for clinical decision-making: implications for outcome selection
por: McNair, Angus, et al.
Publicado: (2015)

Minimal clinically important difference in means in vulnerable populations: challenges and solutions
por: Peacock, Janet L, et al.
Publicado: (2021)

Developing meaningful public involvement in a cancer clinical trials unit
por: Baillie, Jessica, et al.
Publicado: (2015)

Binomial outcomes in dataset with some clusters of size two: can the dependence of twins be accounted for? A simulation study comparing the reliability of statistical methods based on a dataset of preterm infants
por: Sauzet, Odile, et al.
Publicado: (2017)

Making the Fourth Year More Meaningful
por: Sklar, David P.
Publicado: (2014)

Surflex-QMOD: physically meaningful QSAR
por: Steudle, Alexander, et al.
Publicado: (2014)

A distributional approach to obtain adjusted comparisons of proportions of a population at risk
por: Sauzet, Odile, et al.
Publicado: (2016)

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland
por: Martikainen, Jaana E, et al.
Publicado: (2015)

Introducing fuzziness into maximum common substructures for meaningful cluster characterisation
por: Herhaus, Christian
Publicado: (2014)

Trial forge – working together to make trials more efficient
por: Treweek, Shaun
Publicado: (2015)

Citation analysis: a new approach to assess the uptake of core outcome sets
por: Barnes, Karen, et al.
Publicado: (2015)

MetaboAnalyst 3.0—making metabolomics more meaningful
por: Xia, Jianguo, et al.
Publicado: (2015)

Improving analysis practice of continuous adverse event outcomes in randomised controlled trials - a distributional approach
por: Chis Ster, Anca, et al.
Publicado: (2021)

The duration of cost-cutting effects of price-lists
por: Schilling, Ulf Martin
Publicado: (2010)

Core outcome measures in perioperative and anaesthetic care
por: Boney, Oliver, et al.
Publicado: (2015)

The prices outpatients have to pay for purchasing medicines in Armenia
por: Kazaryan, Irina, et al.
Publicado: (2015)

Developing a Drug Price Reference Index in the Philippines
por: Haasis, Manuel A, et al.
Publicado: (2015)

Variation in adverse drug reactions listed in product information for antidepressants and anticonvulsants, between the USA and Europe: a comparison review of paired regulatory documents
por: Cornelius, Victoria R, et al.
Publicado: (2016)

Making arithmetic meaningful
por: Brueckner, Leo J. (Leo John), 1890-1967
Publicado: (1953)

Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)

A201 EFFECT OF MIRIKIZUMAB ON BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT AND REMISSION: RESULTS FROM THE PHASE 3 LUCENT INDUCTION AND MAINTENANCE STUDIES
por: Travis, S, et al.
Publicado: (2023)

The consensus studysquamous cell carcinoma of the oropharynx: late phase clinical trials; core outcomes
por: Waters, Aoife, et al.
Publicado: (2013)

Columnar cell change on core biopsy: radiological features and outcome
por: Stewart, VR, et al.
Publicado: (2006)

The development of a colorectal cancer surgery core outcome set
por: McNair, AGK, et al.
Publicado: (2015)

Core outcomes set for studies on primary prevention of preterm birth
por: van‘t Hooft, Janneke, et al.
Publicado: (2015)

P02.18. Clinically meaningful differences in pain and disability after cupping treatment for chronic neck pain: reanalysis of 4 randomized controlled trials
por: Lauche, R, et al.
Publicado: (2012)

Core outcome set development: the effect of Delphi panel composition and feedback on prioritisation of outcomes
por: Macefield, Rhiannon, et al.
Publicado: (2013)

Making Meaningful Clinical Use of Biomarkers
por: Selleck, Matthew J, et al.
Publicado: (2017)

Cutting costs – the impact of price-lists on the cost development in the emergency department
por: Schilling, Ulf Martin
Publicado: (2009)

Determining the prices of the medicines in the absence of superiority over alternative medical technology
por: Matusewicz, Wojciech, et al.
Publicado: (2015)

Does the admission time make a difference in outcome?
por: Negrão, André, et al.
Publicado: (2015)

The case for a HRQL core outcome set: outcome reporting bias in oesophageal cancer studies
por: Macefield, Rhiannon C, et al.
Publicado: (2011)

The core outcome measures in effectiveness trials (COMET) initiative: five years on
por: Williamson, Paula, et al.
Publicado: (2015)

Cost-efficacy analysis of the MONET trial using Spanish antiretroviral drug prices
por: Arribas, JR, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_35mpgohbc07mh5v6d2d9qd96dt